Catamaran Corp (CTRX) Earning Somewhat Negative Press Coverage, Analysis Shows
News headlines about Catamaran Corp (NASDAQ:CTRX) have been trending somewhat negative this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Catamaran Corp earned a media sentiment score of -0.17 on Accern’s scale. Accern also gave headlines about the healthcare company an impact score of 47.671963219834 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
TRADEMARK VIOLATION NOTICE: This news story was reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/catamaran-corp-ctrx-earning-somewhat-negative-press-coverage-analysis-shows/1528418.html.
About Catamaran Corp
Catamaran Corporation (Catamaran) is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. The Company operates in two segments: PBM and HCIT. The Company offers PBM services, which are marketed under the Catamaran PBM brand, and is engaged in owning and operating a network of mail and specialty pharmacies.
Receive News & Ratings for Catamaran Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catamaran Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.